Patents/Assignees

INTRA-CELLULAR THERAPIES, Inc.

57 patents in portfolio

US12023331utility2024
Methods
0 cites
US11980617utility2024
Methods of Treating Acute Depression And/or Acute Anxiety
0 cites
US11957791utility2024
Methods
0 cites
US11958852utility2024
Compounds and Methods
0 cites
US11872223utility2024
Amorphous Solid Dispersions
0 cites
US11844757utility2023
Organic Compounds
0 cites
US11839614utility2023
Methods for Treating or Mitigating Cardiotoxicity Characterized by Inhibition of Adenosine a 2 Signaling And/or Adenosine a 2 Receptor Expression
0 cites
US11826367utility2023
Amorphous Solid Dispersions
0 cites
US11806347utility2023
Transmucosal Methods for Treating Psychiatric and Neurological Conditions
0 cites
US11806348utility2023
Methods of Treatment Using Pharmaceutical Capsule Compositions Comprising Lumateperone Mono-tosylate
0 cites
US11773095utility2023
Organic Compounds
0 cites
US11759465utility2023
Uses
0 cites
US11753419utility2023
4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7h)-yl)-1-(4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7h)-yl)phenyl)butan-1-one for Treating Conditions of the Central Nervous System and Cardiac Disorders
0 cites
US11723909utility2023
Organic Compounds
0 cites
US11690842utility2023
Pharmaceutical Capsule Compositions Comprising Lumateperone Mono-tosylate
0 cites
US11680065utility2023
Pharmaceutical Compositions Comprising 4-(6br,10as)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro-1h, 7h-pyrido[3′, 4′, 5] Pyrolo[1,2,3-de] Quinoxalin-8yl)-1-(4-fluorophenyl)-butane-1-one and Methods of Treating Conditions of the Central Nervous System
0 cites
US11560382utility2023
Organic Compounds
0 cites

← PreviousPage 3 of 3